D718-1197 Screening compound: 2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]-N~1~-phenylacetamide

D718-1197 Screening compound: 2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]-N~1~-phenylacetamide
D718-1197 Screening compound: 2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]-N~1~-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D718-1197
2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]-N~1~-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D718-1197

Molecular Formula

C23H19N5O2 (C23 H19 N5 O2)

Compound Name

2-[2-oxo-1-(3-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]-N~1~-phenylacetamide

IUPAC name

2-{4-oxo-5-[(pyridin-3-yl)methyl]-257-triazatricyclo[6.4.0.0^{26}]dodeca-1(8)6911-tetraen-3-yl}-N-phenylacetamide

SMILES

O=C(CC(C(N1Cc2cnccc2)=O)n2c1nc1c2cccc1)Nc1ccccc1

InChI

InChI=1S/C23H19N5O2/c29-21(25-17-8-2-1-3-9-17)13-20-22(30)27(15-16-7-6-12-24-14-16)23-26-18-10-4-5-11-19(18)28(20)23/h1-12,14,20H,13,15H2,(H,25,29)/t20-/m0/s1

InChI Key

KSNIZKNUSVPPQC-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD11082283

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

397.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.695

Distribution Coefficient, logD

2.663

Water Solubility, LogSw

-2.87

Polar Surface Area

58.805

Acid Dissociation Constant (pKa)

8.64

Base Dissociation Constant (pKb)

5.60

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

13.00

D718-1197 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D718-1197 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D718-1197?
Check Price and Availability of D718-1197, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D718-1197 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D718-1197
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D718-1197
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D718-1197 available by request